Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(R)-6,8-Dimercaptooctanoic acid, also known as DMSA, is a chelating agent characterized by its ability to bind with heavy metals such as lead, mercury, and arsenic. This property allows it to facilitate the removal of these toxic substances from the body through urine excretion, making it a crucial component in the treatment of heavy metal poisoning.

119365-69-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 119365-69-4 Structure
  • Basic information

    1. Product Name: (R)-6,8-Dimercaptooctanoic acid
    2. Synonyms: R-(+)-Dihydrolipoic acid;(R)-6,8-Dimercaptooctanoic acid
    3. CAS NO:119365-69-4
    4. Molecular Formula: C8H16O2S2
    5. Molecular Weight: 208.34144
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 119365-69-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 361°C
    3. Flash Point: 172°C
    4. Appearance: /
    5. Density: 1.134
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 4.74±0.10(Predicted)
    10. CAS DataBase Reference: (R)-6,8-Dimercaptooctanoic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: (R)-6,8-Dimercaptooctanoic acid(119365-69-4)
    12. EPA Substance Registry System: (R)-6,8-Dimercaptooctanoic acid(119365-69-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 119365-69-4(Hazardous Substances Data)

119365-69-4 Usage

Uses

Used in Medical Applications:
(R)-6,8-Dimercaptooctanoic acid is used as a therapeutic agent for the treatment of heavy metal poisoning, particularly effective in cases of lead poisoning in children and mercury poisoning in adults. It functions by chelating with the heavy metals, aiding in their safe elimination from the body.
Used in Neurological Disorder Treatment:
(R)-6,8-Dimercaptooctanoic acid is used as a potential treatment for certain neurological disorders, such as autism and Parkinson's disease, due to its studied antioxidant and anti-inflammatory properties. These properties may contribute to the mitigation of symptoms associated with these conditions.
Used in Environmental and Occupational Health:
(R)-6,8-Dimercaptooctanoic acid is used as a preventive and interventional measure in cases of exposure to heavy metals in environmental and occupational settings, where individuals may be at risk of developing heavy metal toxicity. Its application helps in reducing the health risks associated with such exposures.

Check Digit Verification of cas no

The CAS Registry Mumber 119365-69-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,3,6 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 119365-69:
(8*1)+(7*1)+(6*9)+(5*3)+(4*6)+(3*5)+(2*6)+(1*9)=144
144 % 10 = 4
So 119365-69-4 is a valid CAS Registry Number.

119365-69-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-6,8-Dimercaptooctanoic acid

1.2 Other means of identification

Product number -
Other names R-6,8-dimercaptooctanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:119365-69-4 SDS

119365-69-4Synthetic route

(R)-1,2-dithiolane-3-pentanoic acid
1200-22-2

(R)-1,2-dithiolane-3-pentanoic acid

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 20℃; for 1h;100%
With 1,4-dihydronicotinamide adenine dinucleotide; porcine heart dihydrolipoamide dehydrogenase at 35℃; Enzyme kinetics;
With sodium borohydrid In water; toluene
Thioctic acid
1077-28-7, 62-46-4

Thioctic acid

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
With sodium borate; sodium hydrogencarbonate
(R)-8-hydroxy-6-mercapto-octanoic acid
101567-87-7

(R)-8-hydroxy-6-mercapto-octanoic acid

thiourea
17356-08-0

thiourea

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
With hydrogen bromide anschliessend mit wss. Natronlauge;
(R)-6,8-Bis-acetylsulfanyl-octanoic acid ethyl ester

(R)-6,8-Bis-acetylsulfanyl-octanoic acid ethyl ester

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
With phosphate buffer pH 7.0; wheatgerm lipase
Methyl (6R)-6,8-diacetyldihydrolipoate
240414-07-7

Methyl (6R)-6,8-diacetyldihydrolipoate

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
With potassium hydroxide; water at 20℃; for 6h; Hydrolysis;
methyl adipoyl chloride
35444-44-1

methyl adipoyl chloride

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: pyridine / CH2Cl2 / 4 h / 20 °C
2: CH2Cl2 / 3 h / 60 °C
3: yeast; EtOH; NaCl / H2O / 37 °C / pH 6.0 / Microbiological reaction
4: 72 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
5: Et3N / CH2Cl2 / 1 h / 0 °C
6: dimethylformamide; cyclohexane / 4 h / 50 °C
7: H2O; KOH / 6 h / 20 °C
View Scheme
Multi-step reaction with 7 steps
1: Ca(OH)2 / CH2Cl2 / 2 h / Heating
2: NH3; H2O / CH2Cl2 / 3 h / 25 °C / pH 9
3: H2 / Ru2Cl4[(S)-BINAP]2*Et3N / methanol / 12 h / 80 °C / 22.5 Torr
4: 82 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
5: Et3N / CH2Cl2 / 1 h / 0 °C
6: dimethylformamide; cyclohexane / 4 h / 50 °C
7: H2O; KOH / 6 h / 20 °C
View Scheme
(6S)-(-)-methyl 6,8-dihydroxyoctanoate
116349-04-3

(6S)-(-)-methyl 6,8-dihydroxyoctanoate

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Et3N / CH2Cl2 / 1 h / 0 °C
2: dimethylformamide; cyclohexane / 4 h / 50 °C
3: H2O; KOH / 6 h / 20 °C
View Scheme
(6S)-(+)-methyl 6,8-bis(methylsulfonyloxy)octanoate
116349-05-4

(6S)-(+)-methyl 6,8-bis(methylsulfonyloxy)octanoate

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide; cyclohexane / 4 h / 50 °C
2: H2O; KOH / 6 h / 20 °C
View Scheme
Stage #1: (6S)-(+)-methyl 6,8-bis(methylsulfonyloxy)octanoate With sodium sulfide; sulfur In methanol
Stage #2: With sodium hydroxide; sodium tetrahydroborate In methanol; water
Stage #3: With methanol; sulfuric acid; water pH=4;
3-oxo-1,8-octanoic acid dimethyl ester
87342-98-1

3-oxo-1,8-octanoic acid dimethyl ester

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: H2 / Ru2Cl4[(S)-BINAP]2*Et3N / methanol / 12 h / 80 °C / 22.5 Torr
2: 82 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
3: Et3N / CH2Cl2 / 1 h / 0 °C
4: dimethylformamide; cyclohexane / 4 h / 50 °C
5: H2O; KOH / 6 h / 20 °C
View Scheme
(3S)-3-hydroxyoctanedioic acid dimethyl ester
142886-33-7

(3S)-3-hydroxyoctanedioic acid dimethyl ester

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 82 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
2: Et3N / CH2Cl2 / 1 h / 0 °C
3: dimethylformamide; cyclohexane / 4 h / 50 °C
4: H2O; KOH / 6 h / 20 °C
View Scheme
1-O-Isobutyl 8-O-methyl 3-oxooctanedioate
142886-30-4

1-O-Isobutyl 8-O-methyl 3-oxooctanedioate

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: yeast; EtOH; NaCl / H2O / 37 °C / pH 6.0 / Microbiological reaction
2: 72 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
3: Et3N / CH2Cl2 / 1 h / 0 °C
4: dimethylformamide; cyclohexane / 4 h / 50 °C
5: H2O; KOH / 6 h / 20 °C
View Scheme
1-O-Isobutyl 8-O-methyl (3S)-3-hydroxyoctanedioate
142886-36-0

1-O-Isobutyl 8-O-methyl (3S)-3-hydroxyoctanedioate

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 72 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
2: Et3N / CH2Cl2 / 1 h / 0 °C
3: dimethylformamide; cyclohexane / 4 h / 50 °C
4: H2O; KOH / 6 h / 20 °C
View Scheme
2-[1-Hydroxy-eth-(E)-ylidene]-3-oxo-octanedioic acid dimethyl ester

2-[1-Hydroxy-eth-(E)-ylidene]-3-oxo-octanedioic acid dimethyl ester

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: NH3; H2O / CH2Cl2 / 3 h / 25 °C / pH 9
2: H2 / Ru2Cl4[(S)-BINAP]2*Et3N / methanol / 12 h / 80 °C / 22.5 Torr
3: 82 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
4: Et3N / CH2Cl2 / 1 h / 0 °C
5: dimethylformamide; cyclohexane / 4 h / 50 °C
6: H2O; KOH / 6 h / 20 °C
View Scheme
6-(2,2-dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidene)-6-hydroxy-hexanoic acid methyl ester
212693-39-5

6-(2,2-dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidene)-6-hydroxy-hexanoic acid methyl ester

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: CH2Cl2 / 3 h / 60 °C
2: yeast; EtOH; NaCl / H2O / 37 °C / pH 6.0 / Microbiological reaction
3: 72 percent / NaBH4 / tetrahydrofuran / 3 h / Heating
4: Et3N / CH2Cl2 / 1 h / 0 °C
5: dimethylformamide; cyclohexane / 4 h / 50 °C
6: H2O; KOH / 6 h / 20 °C
View Scheme
(E)-(S)-6,8-Bis-acetylsulfanyl-oct-4-enoic acid ethyl ester

(E)-(S)-6,8-Bis-acetylsulfanyl-oct-4-enoic acid ethyl ester

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: H2, (PPh3)3RhCl
2: phosphate buffer pH 7.0, wheatgerm lipase
View Scheme
(R)-3-acetylsulfanyl-octanedioic acid-8-ethyl ester
102954-14-3

(R)-3-acetylsulfanyl-octanedioic acid-8-ethyl ester

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: thionyl chloride
2: sodium borate; dioxane / beim Erwaermen des Reaktionsprodukts mit wss.-methanol. Natronlauge und wenig Zink-Pulver
3: aqueous hydrobromic acid / anschliessend mit wss. Natronlauge
View Scheme
(R)-3-acetylsulfanyl-octanedioic acid-8-ethyl ester-1-chloride
104665-85-2

(R)-3-acetylsulfanyl-octanedioic acid-8-ethyl ester-1-chloride

(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium borate; dioxane / beim Erwaermen des Reaktionsprodukts mit wss.-methanol. Natronlauge und wenig Zink-Pulver
2: aqueous hydrobromic acid / anschliessend mit wss. Natronlauge
View Scheme
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

Conditions
ConditionsYield
With sodium borohydrid In water; toluene
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

5-hydroxynaphtho-1,4-quinone
481-39-0

5-hydroxynaphtho-1,4-quinone

5-(2',3'-dihydrospiro[1,3-dithiane-2,3'-[5]hydroxy[1,4]naphthoquinon-4-yl])pentanoic acid
1233347-82-4

5-(2',3'-dihydrospiro[1,3-dithiane-2,3'-[5]hydroxy[1,4]naphthoquinon-4-yl])pentanoic acid

Conditions
ConditionsYield
Stage #1: (R)-6,8-dimercaptooctanoic acid; 5-hydroxynaphtho-1,4-quinone With triethylamine In ethanol for 0.166667h;
Stage #2: With trifluoroacetic acid In ethanol
44%
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

[1,4]naphthoquinone
130-15-4

[1,4]naphthoquinone

5-(2H-3,4-dihydro-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-2-yl)pentanoic acid
1233347-83-5

5-(2H-3,4-dihydro-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-2-yl)pentanoic acid

Conditions
ConditionsYield
Stage #1: (R)-6,8-dimercaptooctanoic acid; [1,4]naphthoquinone With triethylamine In ethanol for 0.166667h;
Stage #2: With trifluoroacetic acid In ethanol
44%
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

5,8-Dihydroxy-1,4-naphthoquinone
475-38-7

5,8-Dihydroxy-1,4-naphthoquinone

5-(2H-3,4-dihydro-7,10-dihydroxy-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-2-yl)pentanoic acid
1233347-84-6

5-(2H-3,4-dihydro-7,10-dihydroxy-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-2-yl)pentanoic acid

Conditions
ConditionsYield
Stage #1: (R)-6,8-dimercaptooctanoic acid; 5,8-Dihydroxy-1,4-naphthoquinone With triethylamine In ethanol for 0.166667h;
Stage #2: With trifluoroacetic acid In ethanol
25%
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

menadione
58-27-5

menadione

A

5-(2',3'-dihydrospiro[1,3-dithiane-2,3'-[2]methyl[1,4]naphthoquinon-4-yl])pentanoic acid

5-(2',3'-dihydrospiro[1,3-dithiane-2,3'-[2]methyl[1,4]naphthoquinon-4-yl])pentanoic acid

B

C30H28O6S2
1233347-87-9

C30H28O6S2

Conditions
ConditionsYield
With triethylamine In ethanol for 2h;A 20%
B 16%
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

bis-(4-dimethylamino-phenyl)-carbodiimide
738-65-8

bis-(4-dimethylamino-phenyl)-carbodiimide

N-((R)-6,8-dimercapto-octanoyl)-N,N'-bis-(4-dimethylamino-phenyl)-urea

N-((R)-6,8-dimercapto-octanoyl)-N,N'-bis-(4-dimethylamino-phenyl)-urea

Conditions
ConditionsYield
With diethyl ether
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

(R)-1,2-dithiolane-3-pentanoic acid
1200-22-2

(R)-1,2-dithiolane-3-pentanoic acid

Conditions
ConditionsYield
With iron(III) chloride; potassium carbonate
With chloroform; iodine; potassium iodide
With mushroom tyrosinase
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

lithium-

lithium-

(R)-6-acetylsulfanyl-8-mercapto-octanoic acid
91007-40-8

(R)-6-acetylsulfanyl-8-mercapto-octanoic acid

Conditions
ConditionsYield
With enzyme-substance from escherichia coli
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

(R)-6-acetylsulfanyl-8-mercapto-octanoic acid methyl ester

(R)-6-acetylsulfanyl-8-mercapto-octanoic acid methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: enzyme-substance from escherichia coli
2: benzene
View Scheme
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

N-((R)-6-acetylsulfanyl-8-mercapto-octanoyl)-N,N'-bis-(4-dimethylamino-phenyl)-urea

N-((R)-6-acetylsulfanyl-8-mercapto-octanoyl)-N,N'-bis-(4-dimethylamino-phenyl)-urea

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: enzyme-substance from escherichia coli
2: diethyl ether; petroleum ether
View Scheme
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

N-((R)-8-acetylsulfanyl-6-mercapto-octanoyl)-N,N'-bis-(4-dimethylamino-phenyl)-urea

N-((R)-8-acetylsulfanyl-6-mercapto-octanoyl)-N,N'-bis-(4-dimethylamino-phenyl)-urea

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: diethyl ether
2: pyridine
View Scheme
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

5-hydroxynaphtho-1,4-quinone
481-39-0

5-hydroxynaphtho-1,4-quinone

A

5-(2H-3,4-dihydro-7-hydroxy-6,11-dioxonaphtho[3,2-b][1,4]dithiepin-2-yl)pentanoic acid
1233347-80-2

5-(2H-3,4-dihydro-7-hydroxy-6,11-dioxonaphtho[3,2-b][1,4]dithiepin-2-yl)pentanoic acid

B

5-(2H-3,4-dihydro-7-hydroxy-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-4-yl)pentanoic acid
1233347-81-3

5-(2H-3,4-dihydro-7-hydroxy-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-4-yl)pentanoic acid

Conditions
ConditionsYield
With triethylamine In ethanol for 0.166667h;
(R)-6,8-dimercaptooctanoic acid
119365-69-4

(R)-6,8-dimercaptooctanoic acid

juglone acetate
5196-28-1

juglone acetate

A

5-(7-acetoxy-2H-3,4-dihydro-6,11-dioxonaphtho[3,2-b][1,4]dithiepin-2-yl)pentanoic acid
1233347-85-7

5-(7-acetoxy-2H-3,4-dihydro-6,11-dioxonaphtho[3,2-b][1,4]dithiepin-2-yl)pentanoic acid

B

5-(7-acetoxy-2H-3,4-dihydro-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-4-yl)pentanoic acid
1233347-86-8

5-(7-acetoxy-2H-3,4-dihydro-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-4-yl)pentanoic acid

Conditions
ConditionsYield
With triethylamine In ethanol for 0.166667h;

119365-69-4Relevant articles and documents

Reaction of dihydrolipoic acid with juglone and related naphthoquinones: unmasking of a spirocyclic 1,3-dithiane intermediate en route to naphtho[1,4]dithiepines

Greco, Giorgia,Panzella, Lucia,Pezzella, Alessandro,Napolitano, Alessandra,d'Ischia, Marco

, p. 3912 - 3916 (2010)

The reaction of dihydrolipoic acid (DHLA) with 5-hydroxy-1,4-naphthoquinone (juglone) gives rise to the novel naphtho[1,4]dithiepine derivatives through ring expansion of an unstable spirocyclic 1,3-dithiane intermediate, which was isolated and completely characterized. Reported herein is also the characterization of novel reaction products of DHLA with other naphthoquinones and the extension of the study to the spirocyclic adduct formed by reaction with a representative 2-substituted naphthoquinone.

STEREOSELECTIVE REDUCTION OF RACEMIC N-HYDROXYAMINO ACIDS BY OPTICALLY ACTIVE THIOLS-IRON(II)

Nambu, Yoko,Endo, Takeshi

, p. 999 - 1002 (1985)

Kinetic resolution of racemic N-hydroxyamino acids by the reduction with optically active thiols and a catalytic amount of ferrous ion gave optically active amino acids presumably through enantiodifferentiating coordination of substrates to thiol-Fe(II) complexes.

Physicochemical Profiling of α-Lipoic Acid and Related Compounds

Mirzahosseini, Arash,Szilvay, András,Noszál, Béla

, p. 861 - 869 (2016)

Lipoic acid, the biomolecule of vital importance following glycolysis, shows diversity in its thiol/disulfide equilibria and also in its eight different protonation forms of the reduced molecule. In this paper, lipoic acid, lipoamide, and their dihydro derivatives were studied to quantify their solubility, acid–base, and lipophilicity properties at a submolecular level. The acid–base properties are characterized in terms of six macroscopic, 12 microscopic protonation constants, and three interactivity parameters. The species-specific basicities, the pH-dependent distribution of the microspecies, and lipophilicity parameters are interpreted by various intramolecular effects, and contribute to understanding the antioxidant, chelate-forming, and enzyme cofactor behavior of the molecules observed.

METHOD FOR PRODUCING DIHYDROLIPOIC ACID AND SALT THEREOF

-

Paragraph 0017; 0074, (2018/08/09)

PROBLEM TO BE SOLVED: To provide a production method that is suitable for industrial production, and makes it possible to obtain dihydrolipoic acid with high purity and high optical purity or a salt thereof. SOLUTION: A method for producing dihydrolipoic acid or a salt thereof includes the step of reducing α-lipoic acid or a salt thereof in an aqueous or organic liquid phase by an electrode reaction. SELECTED DRAWING: Figure 1 COPYRIGHT: (C)2018,JPO&INPIT

Circularly polarized luminescence in chiral silver nanoclusters

Kumar, Jatish,Kawai, Tsuyoshi,Nakashima, Takuya

supporting information, p. 1269 - 1272 (2017/02/05)

Silver nanoclusters (NCs) capped with enantiomeric bidentate ligands exhibited mirror image circularly polarized luminescence (CPL) spectra with an anisotropy factor of 0.2%. Chirality in the ligand staples is most likely responsible for the induction of optical activity in the emissive state.

Shikonin thioctic ester derivatives as well as synthetic method and application thereof

-

Paragraph 0020, (2017/11/30)

The invention belongs to the technical field of chemical pharmaceuticals and in particular relates to shikonin thioctic ester derivatives and an application thereof in tumor suppression. Corresponding thioctic ester derivatives are connected with shikonin through synthetic means so as to obtain corresponding ester derivatives. In-vitro anti-tumor activity study proves that the shikonin thioctic ester derivatives have excellent inhibitory activities on tumor cell strains.

METHOD FOR THE PURIFICATION OF LIPONIC ACID

-

Page/Page column 4-5, (2008/06/13)

The invention relates to a method for the purification of liponic acid wherein at least O.1 times the amount of an adsorption agent is added to a solution of liponic acid in relation to the mass of liponic acid to be purified and the adsorption agent is then separated. As a result, it is possible to produce racemic or non-racemic liponic acid with less than 1 wt. % oligomers, e.g. 0.11 wt. %.

A short and productive synthesis of (R)-α-Lipoic acid

Bringmann, Gerhard,Herzberg, Daniela,Adam, Geo,Balkenhohl, Friedhelm,Paust, Joachim

, p. 655 - 661 (2007/10/03)

(R)-α-Lipoic acid is synthesized in seven steps from the base chemicals methyl acetoacetate or Meldrum's acid and monomethyl adipate. The key steps are the introduction of the stereogenic center by fermentative or homogeneously catalyzed hydrogenation of 3-oxooctanedioic acid diester to (3S)-3-hydroxyoctanedioic acid diester and its regioselective reduction to (6S)-6,8-dihydroxyoctanoic acid ester. The overall yield of (R)-α-lipoic acid, starting from 3-oxooctanedioic acid diester, is 40%.

Lipase catalyzed regio- and stereospecific hydrolysis: Chemoenzymatic synthesis of both (R)- and (S)-enantiomers of α-lipoic acid

Fadnavis,Babu, Ravi Luke,Vadivel, S. Kumara,Deshpande, Ashlesha A.,Bhalerao

, p. 4109 - 4112 (2007/10/03)

Native lipase of Candida rugosa (EC 3.1.1.3) enantioselectively and regiospecifically hydrolyses the n-butyl ester of 2,4-dithioacetyl butanoic acid either at the carboxylic acid terminus or at the α-thioacetate to provide enantiomerically pure (R)-2,4-dithioacetyl butyric acid and (S)- butyl 2-thio-4-thioacetyl butyrate (ee >98%) while the lipase modified by treatment with diethyl p-nitrophenyl phosphate attacks only the α- thioacetate giving enantiomerically pure (S)-butyl 2-thio-4-thioacetyl butyrate. These enantiomerically pure intermediates can be used as chiral building blocks to obtain both(S)- and (R)-enantiomers of α-lipoic acid and their analogues.

Interaction of α-Lipoic acid Enantiomers and Homologues with the Enzyme Components of the Mammalian Pyruvate Dehydrogenase Complex

Loeffelhardt, Sabine,Bonaventura, Christoph,Locher, Mathias,Borbe, Harald O.,Bisswanger, Hans

, p. 637 - 646 (2007/10/03)

Lipoic acid (α-lipoic acid, thioctic acid) is applied as a therapeutic agent in various diseases accompanied by polyneuropathia such as diabetes mellitus. The stereoselectivity and specificity of lipoic acid for the pyruvate dehydrogenase complex and its component enzymes from different sources has been studied. The dihydrolipoamide dehydrogenase component from pig heart has a clear preference for R-lipoic acid, a substrate which reacts 24 times faster than the S-enantiomer. Selectivity is more at the stage of the catalytic reaction than of binding. The Michaelis constants of both enantiomers are comparable (Km = 3.7 and 5.5 mM for R- and S-lipoic acid, respectively) and the S-enantiomer inhibits the R-lipoic acid dependent reaction with an inhibition constant similar to its Michaelis constant. When three lipoic acid homologues were tested, RS-1,2-dithiolane-3-caproic acid was one carbon atom longer than lipoic acid, while RS-bisnorlipoic acid and RS-tetranorlipoic acid were two and four carbon atoms shorter, respectively. All are poor substrates but bind to and inhibit the enzyme with an affinity similar to that of S-lipoic acid. No essential differences with respect to its reaction with lipoic acid enantiomers and homologues exist between free and complex-bound dihydrolipoamide dehydrogenase. Dihydrolipoamide dehydrogenase from human renal carcinoma has a higher Michaelis constant for R-lipoic acid (Km = 18 mM) and does not accept the S-enantiomer as a substrate. Both enantiomers of lipoic acid are inhibitors of the overall reaction of the bovine pyruvate dehydrogenase complex, but stimulate the respective enzyme complexes from rat as well as from Escherichia coli. The S-enantiomer is the stronger inhibitor, the R-enantiomer the better activator. The two enantiomers have no influence on the partial reaction of the bovine pyruvate dehydrogenase component, but do inhibit this enzyme component from rat kidney. The implications of these results are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 119365-69-4